Education
About Us
Working with TipRanks
Follow Us
Intelligent Bio Solutions (INBS)
NASDAQ:INBS
Total Valuation
Intelligent Bio Solutions has a market cap or net worth of $14.55M. The enterprise value is $11.68M.
Market Cap$14.55M
Enterprise Value$11.68M
Share Statistics
Intelligent Bio Solutions has 8,979,152 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,979,152
Owned by Insiders1.27%
Owned by Institutions8.26%
Financial Efficiency
Intelligent Bio Solutions’s return on equity (ROE) is -3.53 and return on invested capital (ROIC) is -334.68%.
Return on Equity (ROE)-3.53
Return on Assets (ROA)-1.28
Return on Invested Capital (ROIC)-334.68%
Return on Capital Employed (ROCE)-3.67
Revenue Per Employee61.05K
Profits Per Employee-211.37K
Employee Count50
Asset Turnover0.37
Inventory Turnover2.84
Valuation Ratios
The current PE Ratio of Intelligent Bio Solutions is ―. Intelligent Bio Solutions’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value3.03
Price to FCF―
Price to Operating Cash Flow-0.26
PEG Ratio―
Income Statement
In the last 12 months, Intelligent Bio Solutions had revenue of 3.05M and earned -10.57M in profits. Earnings per share was -2.00.
Revenue3.05M
Gross Profit1.25M
Operating Income-10.64M
Pretax Income-10.57M
Net Income-10.57M
EBITDA-9.34M
Earnings Per Share (EPS)-2.00
Cash Flow
In the last 12 months, operating cash flow was -9.68M and capital expenditures -231.84K, giving a free cash flow of -9.91M billion.
Operating Cash Flow-9.68M
Free Cash Flow-9.91M
Free Cash Flow per Share-1.10
Dividends & Yields
Intelligent Bio Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.05
52-Week Price Change21.80%
50-Day Moving Average1.68
200-Day Moving Average1.63
Relative Strength Index (RSI)53.56
Average Volume (3m)165.85K
Important Dates
Intelligent Bio Solutions upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 15, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Intelligent Bio Solutions as a current ratio of 0.77, with Debt / Equity ratio of 9.41%
Current Ratio0.77
Quick Ratio0.65
Debt to Market Cap0.03
Net Debt to EBITDA0.08
Interest Coverage Ratio-174.82
Taxes
In the past 12 months, Intelligent Bio Solutions has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Intelligent Bio Solutions EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -0.84.
EV to Sales2.73
EV to EBITDA-0.89
EV to Free Cash Flow-0.84
EV to Operating Cash Flow-0.86
Balance Sheet
Intelligent Bio Solutions has $1.02M in cash and marketable securities with $281.81K in debt, giving a net cash position of -$738.10K billion.
Cash & Marketable Securities$1.02M
Total Debt$281.81K
Net Cash-$738.10K
Net Cash Per Share-$0.08
Tangible Book Value Per Share-$0.19
Margins
Gross margin is 40.85%, with operating margin of -348.71%, and net profit margin of -346.23%.
Gross Margin40.85%
Operating Margin-348.71%
Pretax Margin-346.23%
Net Profit Margin-346.23%
EBITDA Margin-305.85%
EBIT Margin-345.42%
Analyst Forecast
The average price target for Intelligent Bio Solutions is $1.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.50
Price Target Upside-7.41% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-1.90%
EPS Growth Forecast87.72%